Background: Tramadol is an analgesic drug being abused today a lot. Excessive ingestion will lead
INTRODUCTION
Tramadol ingestion has been one of the main reasons of drug poisoning in Iran during recent years and deliberate self-poisoning has been reported as the major reason [1] . Tramadol is an opioid-like analgesic used for the treatment of moderate to severe pains. At the first glance, the most common and obvious side effects due to tramadol usage or abusement are independent convulsion to this drug [2] [3] [4] [5] [6] . However, particularly in cases with excessive ingestion, it leads to bradycardia, apnea, headache, dysphoria, and even coma in addition to convulsion [7] [8] [9] .
Tramadol can develop convulsion and some other side effects even with pharmaceutical doses, with increase in ingestion, side effects appear more [10, 11] . One of the main complications caused by tramadol poisoning is apnea. Despite, vast majority of specialists' belief, tramadol can cause apnea and consequently death [12] . The main reason of death in patients with more than 5 gr tramadol ingestion is cardiorespiratory arrest. This study aimed to investigate the frequency of respiratory apnea due to tramadol ingestion and take special notice to this life-threatening side effect frequently ignored by medical doctors compared with more common disorders like convulsion easily treated by enough doses of naloxone or tracheal intubation. Therefore, it is required to pay more attention to it than past.
MATERIALS AND METHODS
In this prospective cross-sectional study, all patients purely poisoned by tramadol, hospitalized at poisoning ward of Farshchian Hospital in Hamadan, Iran, from Jan 2014 to Dec 2015 were included.
Ethics Committee of Hamadan University of Medical Sciences approved the study. Informed consent was taken from the patients.
Demographic data including age, gender, poisoning sort (intentional and unintentional), drug ingestion dose and respiratory apnea leading to Volume 12, No 2, March-April 2018; http://www.ijt.ir taking naloxone or intubation was registered. Based on the exclusion criteria, all patients with history or evidence of respiratory diseases or those taken any other drug in addition to tramadol were eliminated.
The collected data were analyzed by SPSS software (ver. 16, Chicago, IL, USA), MannWhitney, Chi-square, and t-tests. The P-value <0.05 was considered statistically significant. The mean age of patients who developed apnea was 32.48 yr and patients without apnea development were 25.18 yr; so Mann-Whitney test demonstrated that this difference was statistically significant. In other words, apnea development was more among patients with higher mean age. The most frequency was observed in 20-30 yr-old patients which were statistically significant (P <0.05) ( Table 2) . The mean dose of tramadol ingestion among patients who developed apnea was 4158.83 mg, however, among patients without apnea development was 1222.38 mg. The Mann-Whitney test turned out that this difference was statistically significant (P=0.00001) ( Table 3) . Among patients with apnea development, 4 people (23.52%) were required to take intubation and others were treated by naloxone. Eventually, only one patient (0.29%) died due to tramadol poisoning during the two-yr study.
RESULTS

Overall
DISCUSSION
A number of patients developed apnea. The mean age of under-studying patients was 25.53 yr, which demonstrate young people are more in danger of developing tramadol poisoning. In a study, the mean age of patients was 22.5 yr [13] and 23.29 in another study [14] . About 80% of people referred to drugstores to get tramadol were under 18 yr old [15] .
In the current study, most patients were male [14, 15] . The risk of tramadol poisoning is more among males rather than females, which may be due to easier access to tramadol by males or less report of its ingestion among females since it is considered unacceptable [16] . Ten male and 7 female patients developed apnea that no statistically significant difference was observed from gender aspect. In this study, most patients had deliberate self-poisoning and the other patients had claimed their ingestion unintentional. Deliberate selfpoisoning was more than our study's statistics [13] .
Current study demonstrated that 17 patients (4.86%) out of 350 under-studying patients developed apnea. Four patients were treated by intubation and 13 patients by naloxone injection. Only nine patients (3.6%) out of 525 poisoned patients due to tramadol ingestion developed apnea [12] whose results went well with our study that demonstrates the scarcity of this disorder. The mean tramadol ingestion dose in patients with apnea development was more than patients not developed that disorder. The mean tramadol ingestion dose among those patients developed apnea was 4158.83 mg and among those without apnea, development http://www.ijt.ir; Volume 12, No 2, March-April 2018 was 1222.38 mg. This difference was statistically significant. The mean tramadol ingestion dose has been 2500 mg in patients with apnea development and 1000 mg in patients who did not develop apnea [17] and in our study, the mean ingestion dose was 4000 mg among those who developed apnea and 1200 mg for those who did not. The mean tramadol ingestion dose in males was 1434.23 mg and in females was 115.75 mg that was statistically significant. The mean ingestion dose in males and females were reported 2413 and 1706 mg, respectively, which went well with our study's results [5] . During two-yr study, only one patient (0.29%) out of completely poisoned patients died eventually which was less than some other studies [18] [19] [20] .
CONCLUSION
Although respiratory apnea is less frequent compared with other more common disorders due to excessive tramadol ingestion; it has been the potentially life-threatening risk. Due to vast majority of specialists' recommendation, so as not to prescribe naloxone to prevent probable convulsion, this significant issue can be ignored and the result in irremediable implications for the patients. Therefore, specialists must not ignore it.
